Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-13-004351
Filing Date
2013-04-12
Accepted
2013-04-12 12:14:02
Documents
11
Period of Report
2013-02-28

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q immucor_10q-022813.htm 10-Q 1863641
2 EXHIBIT 31.1 ex31-1.htm EX-31.1 15296
3 EXHIBIT 31.2 ex31-2.htm EX-31.2 16599
4 EXHIBIT 32.1 ex32-1.htm EX-32.1 6091
5 EXHIBIT 32.2 ex32-2.htm EX-32.2 5982
  Complete submission text file 0001437749-13-004351.txt   18073852

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE blud-20130228.xml EX-101.INS 4625254
7 XBRL TAXONOMY EXTENSION SCHEMA blud-20130228.xsd EX-101.SCH 71530
8 XBRL TAXONOMY EXTENSION CALCULATION blud-20130228_cal.xml EX-101.CAL 54316
9 XBRL TAXONOMY EXTENSION DEFINITION blud-20130228_def.xml EX-101.DEF 410777
10 XBRL TAXONOMY EXTENSION LABELS blud-20130228_lab.xml EX-101.LAB 472519
11 XBRL TAXONOMY EXTENSION PRESENTATION blud-20130228_pre.xml EX-101.PRE 417683
Mailing Address 3130 GATEWAY DR P O BOX 5625 NORCROSS GA 30091-5625
Business Address 3130 GATWAY PO BOX 5625 NORCROSS GA 30091 770 441 2051
IMMUCOR INC (Filer) CIK: 0000736822 (see all company filings)

EIN.: 222408354 | State of Incorp.: GA | Fiscal Year End: 0531
Type: 10-Q | Act: 34 | File No.: 000-14820 | Film No.: 13758096
SIC: 2835 In Vitro & In Vivo Diagnostic Substances